NASDAQ:LQDA Liquidia (LQDA) Stock Price, News & Analysis $9.10 +0.04 (+0.44%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$8.96▼$9.3850-Day Range$8.94▼$14.1152-Week Range$5.71▼$16.99Volume970,056 shsAverage Volume999,576 shsMarket Capitalization$694.99 millionP/E RatioN/ADividend YieldN/APrice Target$23.14 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Liquidia alerts: Email Address Liquidia MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.75 Rating ScoreUpside/Downside154.5% Upside$23.14 Price TargetShort InterestBearish16.35% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.08Based on 10 Articles This WeekInsider TradingAcquiring Shares$1.43 M Bought Last QuarterProj. Earnings GrowthGrowingFrom ($1.71) to ($1.43) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.41 out of 5 starsMedical Sector264th out of 910 stocksPharmaceutical Preparations Industry110th out of 426 stocks 4.4 Analyst's Opinion Consensus RatingLiquidia has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 5 buy ratings, 1 hold rating, and 1 sell rating.Amount of Analyst CoverageLiquidia has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Liquidia's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted16.35% of the outstanding shares of Liquidia have been sold short.Short Interest Ratio / Days to CoverLiquidia has a short interest ratio ("days to cover") of 10.7, which indicates bearish sentiment.Change versus previous monthShort interest in Liquidia has recently decreased by 2.95%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldLiquidia does not currently pay a dividend.Dividend GrowthLiquidia does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for LQDA. Previous Next 2.3 News and Social Media Coverage News SentimentLiquidia has a news sentiment score of 0.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 10 news articles for Liquidia this week, compared to 4 articles on an average week.Search Interest13 people have searched for LQDA on MarketBeat in the last 30 days. This is an increase of 1,200% compared to the previous 30 days.MarketBeat FollowsOnly 3 people have added Liquidia to their MarketBeat watchlist in the last 30 days. This is a decrease of -25% compared to the previous 30 days. Previous Next 5.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Liquidia insiders have bought 455.06% more of their company's stock than they have sold. Specifically, they have bought $1,426,500.00 in company stock and sold $256,998.00 in company stock.Percentage Held by Insiders31.60% of the stock of Liquidia is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions64.54% of the stock of Liquidia is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Liquidia's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Liquidia are expected to grow in the coming year, from ($1.71) to ($1.43) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Liquidia is -5.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Liquidia is -5.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioLiquidia has a P/B Ratio of 11.09. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Liquidia's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. Hopelessness abounds. And looking in, the future here looks bleak for these forgotten souls. But in a strange twist of fate, something miraculous is taking place…Go here now to watch my new documentary About Liquidia Stock (NASDAQ:LQDA)Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.Read More LQDA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LQDA Stock News HeadlinesSeptember 5 at 7:27 AM | insidertrades.comLiquidia Co. (NASDAQ:LQDA) CFO Michael Kaseta Sells 1,079 SharesSeptember 5 at 4:00 PM | prnewswire.comBronstein, Gewirtz and Grossman, LLC Announces an Investigation Against Liquidia Technologies, Inc. (LQDA) and Encourages Shareholders to Seek Compensation for Alleged WrongdoingsSeptember 7, 2024 | Porter & Company (Ad)Trump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. Hopelessness abounds. And looking in, the future here looks bleak for these forgotten souls. But in a strange twist of fate, something miraculous is taking place…September 5 at 6:39 AM | americanbankingnews.comLiquidia Co. (NASDAQ:LQDA) Director Caligan Partners Lp Acquires 150,000 SharesSeptember 3, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia Corporation - LQDASeptember 2, 2024 | globenewswire.comLiquidia Technologies, Inc. (LQDA) Investigation: Bronstein, Gewirtz and Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsAugust 30, 2024 | stockhouse.comLiquidia Corp. May Be Liable To Compensate Shareholders And The Schall Law Firm Wants The Public's Help In An InvestigationAugust 28, 2024 | prnewswire.comBronstein, Gewirtz and Grossman, LLC Announces an Investigation Against Liquidia Technologies, Inc. (LQDA) and Encourages Shareholders to Seek Compensation for Alleged WrongdoingsSeptember 7, 2024 | Porter & Company (Ad)Trump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. Hopelessness abounds. And looking in, the future here looks bleak for these forgotten souls. But in a strange twist of fate, something miraculous is taking place…August 28, 2024 | globenewswire.comLiquidia to Present at Upcoming Investor ConferencesAugust 27, 2024 | globenewswire.comLIQUIDIA ALERT: Bragar Eagel & Squire, P.C. is Investigating Liquidia Corporation on Behalf of Liquidia Stockholders and Encourages Investors to Contact the FirmAugust 27, 2024 | globenewswire.comLiquidia Technologies, Inc. (LQDA) Investigation: Bronstein, Gewirtz and Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsAugust 27, 2024 | msn.comJim Cramer Says Liquidia Corporation (LQDA) Has Been Going ‘Down, Down, Down'August 26, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia Corporation - LQDAAugust 26, 2024 | finance.yahoo.comJim Cramer Says Liquidia Corporation (LQDA) Has Been Going ‘Down, Down, Down’August 24, 2024 | stockhouse.comLiquidia Corp Is Being Inquired Into By The Schall Law Firm For Securities Law Infractions And Stakeholders Can Play A PartAugust 22, 2024 | markets.businessinsider.comBuy Rating Affirmed: Liquidia Technologies’ Proactive Legal Strategies and Favorable OutlookAugust 22, 2024 | msn.comLiquidia challenges exclusivity blocking Yutrepia in new lawsuitSee More Headlines Receive LQDA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Liquidia and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/07/2024Today9/07/2024Next Earnings (Estimated)11/05/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryMedical Equipment Current SymbolNASDAQ:LQDA CUSIPN/A CIK1819576 Webwww.liquidia.com Phone(919) 328-4400FaxN/AEmployees50Year FoundedN/APrice Target and Rating Average Stock Price Target$23.14 High Stock Price Target$30.00 Low Stock Price Target$3.00 Potential Upside/Downside+154.5%Consensus RatingModerate Buy Rating Score (0-4)2.75 Research Coverage8 Analysts Profitability EPS (Most Recent Fiscal Year)($1.56) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-78,500,000.00 Net Margins-755.46% Pretax Margin-755.46% Return on Equity-183.57% Return on Assets-74.19% Debt Debt-to-Equity RatioN/A Current Ratio6.08 Quick Ratio5.78 Sales & Book Value Annual Sales$14.84 million Price / Sales46.83 Cash FlowN/A Price / Cash FlowN/A Book Value$0.82 per share Price / Book11.09Miscellaneous Outstanding Shares76,414,000Free Float52,267,000Market Cap$694.99 million OptionableOptionable Beta0.22 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesDr. Roger A. Jeffs Ph.D. (Age 62)CEO & Director Comp: $1.32MMr. Michael Kaseta (Age 48)COO & CFO Comp: $890.8kMr. Russell Schundler (Age 49)General Counsel & Corporate Secretary Comp: $778.49kMr. William R. Kenan Jr.Co-FounderDr. Ginger DenisonCo-FounderMs. Sarah Krepp SPHRVice President of People & CultureMr. Jason Adair (Age 52)Chief Business Officer Mr. Scott Moomaw (Age 53)Chief Commercial Officer Dr. Rajeev Saggar M.D. (Age 50)Chief Medical Officer Mr. Michael HunterSenior Vice President of Manufacturing OperationsMore ExecutivesKey CompetitorsHeron TherapeuticsNASDAQ:HRTXPro-DexNASDAQ:PDEXDURECTNASDAQ:DRRXDarioHealthNASDAQ:DRIOBeyond AirNASDAQ:XAIRView All CompetitorsInsiders & InstitutionsRussell SchundlerSold 710 sharesTotal: $6,745.00 ($9.50/share)Michael KasetaSold 1,079 sharesTotal: $10,250.50 ($9.50/share)Jason AdairSold 455 sharesTotal: $4,322.50 ($9.50/share)Caligan Partners LpBought 150,000 shares on 8/30/2024Total: $1.43 M ($9.51/share)Susquehanna International Group LLPSold 227,400 shares on 8/16/2024Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions LQDA Stock Analysis - Frequently Asked Questions How have LQDA shares performed this year? Liquidia's stock was trading at $12.03 at the beginning of 2024. Since then, LQDA stock has decreased by 24.4% and is now trading at $9.0950. View the best growth stocks for 2024 here. How were Liquidia's earnings last quarter? Liquidia Co. (NASDAQ:LQDA) released its earnings results on Wednesday, August, 7th. The company reported ($0.37) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.35) by $0.02. The firm earned $3.66 million during the quarter, compared to analysts' expectations of $7.92 million. Liquidia had a negative trailing twelve-month return on equity of 183.57% and a negative net margin of 755.46%. When did Liquidia IPO? Liquidia (LQDA) raised $50 million in an initial public offering (IPO) on Thursday, July 26th 2018. The company issued 4,500,000 shares at a price of $10.00-$12.00 per share. Jefferies and Cowen acted as the underwriters for the IPO and Needham & Company and Wedbush PacGrow were co-managers. Who are Liquidia's major shareholders? Liquidia's top institutional shareholders include Susquehanna International Group LLP, Bank of New York Mellon Corp (0.27%), HighVista Strategies LLC (0.16%) and Squarepoint Ops LLC (0.11%). Insiders that own company stock include Caligan Partners Lp, Russell Schundler, Michael Kaseta, Rajeev Saggar, Robert A Lippe, Scott Moomaw, Jason Adair and Arthur S Kirsch. View institutional ownership trends. How do I buy shares of Liquidia? Shares of LQDA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Liquidia own? Based on aggregate information from My MarketBeat watchlists, some other companies that Liquidia investors own include VBI Vaccines (VBIV), OPKO Health (OPK), Aldeyra Therapeutics (ALDX), Sorrento Therapeutics (SRNE), vTv Therapeutics (VTVT), Genocea Biosciences (GNCA) and Inovio Pharmaceuticals (INO). This page (NASDAQ:LQDA) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredThe death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Liquidia Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Liquidia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
